Physician profile
Alison A Heaton
NPI 1649289703
$5,076.33
in general payments reported to CMS, 2019-2025
46 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $364 · 2021: $813 · 2022: $629 · 2023: $769 · 2024: $1,565 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833 · Travel and Lodging: $623 · Education: $217 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.41 |
| Travel and Lodging | $623.09 |
| Education | $216.95 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,187.97 | 2019-2024 | Da Vinci Surgical System |
| Abbvie INC. | $825.01 | 2019-2025 | |
| Astellas Pharma US INC | $465.87 | 2020-2024 | Veozah, Myrbetriq |
| Ethicon US, LLC | $255.06 | 2020-2025 | Stratafix, Ethicon, Dermabond Prineo |
| Pfizer INC. | $184.59 | 2019-2024 | |
| Hologic Sales and Service, LLC | $171.68 | 2019-2024 | Aptima, Omni Hysteroscope, Novasure |
| Aspira Women'S Health INC | $143.73 | 2022 | |
| Coopersurgical, INC. | $124.95 | 2020-2025 | Endosee, Paragard T 380a |
| Mayne Pharma Commercial LLC | $119.40 | 2021-2025 | |
| Myriad Women'S Health, INC. | $107.99 | 2023 | Myrisk |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $95.76 | 2019 | |
| Amgen INC. | $93.08 | 2019-2021 | |
| Medical Device Business Services, INC. | $93.00 | 2025 | Enseal |
| Evofem Biosciences, INC. | $91.51 | 2021-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $84.42 | 2019-2025 | Slynd |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Heaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.